| 注册
首页|期刊导航|中国临床药理学与治疗学|青少年子宫内膜异位症药物治疗选择及药物治疗进展

青少年子宫内膜异位症药物治疗选择及药物治疗进展

黄春芝 刘青蓝 苏冉 孙楠

中国临床药理学与治疗学2024,Vol.29Issue(5):535-542,8.
中国临床药理学与治疗学2024,Vol.29Issue(5):535-542,8.DOI:10.12092/j.issn.1009-2501.2024.05.008

青少年子宫内膜异位症药物治疗选择及药物治疗进展

Drug treatment options and research progress of adolescent endo-metriosis

黄春芝 1刘青蓝 1苏冉 1孙楠1

作者信息

  • 1. 郑州大学第三附属医院药学部,郑州 450052,河南
  • 折叠

摘要

Abstract

Endometriosis is a chronic,relapsing disease that requires long-term management.Ado-lescent endometriosis is a group that can be ig-nored,and the drug treatment is an important method for long-term management and fertility preservation.There are many kinds of drugs to treat endometriosis,such as NSAIDs,combined oral contraceptives(COC),progesterone,GnRHa.For the drug treatment selection,the characteris-tics of adolescents should be carefully considered and individualized treatment should be provided.In order to better long-term management,it is nec-essary to develop new treatments,which can effec-tively relieve endometriosis without damaging fer-tility.This review focuses on the drug treatment op-tions and research progress of basic drug treat-ment for adolescent endometriosis,so as to delay disease progression,reduce adverse reactions,pre-serve fertility,and improve quality of life.

关键词

青少年子宫内膜异位症/药物治疗/进展

Key words

adolescent endometriosis/drug treat-ment/progress of drug therapy

分类

医药卫生

引用本文复制引用

黄春芝,刘青蓝,苏冉,孙楠..青少年子宫内膜异位症药物治疗选择及药物治疗进展[J].中国临床药理学与治疗学,2024,29(5):535-542,8.

基金项目

河南省医学科技攻关计划(联合共建)项目(LHGJ20190403) (联合共建)

中国临床药理学与治疗学

OA北大核心CSTPCD

1009-2501

访问量0
|
下载量0
段落导航相关论文